PMID: 3214581Dec 1, 1988Paper

Neoplasms of the central nervous system in Norway. II. Descriptive epidemiology of intracranial neoplasms 1955-1984

APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica
A HelsethS J Mørk

Abstract

A population-based study of 8480 patients - 4508 (53%) males and 3972 females - with primary intracranial neoplasms reported to the Norwegian Cancer Registry during the period 1955-84, is presented. 81% of the cases were histologically verified. The peak age-specific incidence rate in the total series occurred in the age-group 55-64 years. Gliomas constituted the largest histological group with an age-adjusted incidence rate of 5.0 cases per 100,000 population per year for males and 3.5 for females. Case ascertainment of primary intracranial neoplasms is reduced above the age of 60 in Norway, mostly due to a a low autopsy rate. The major impact of the introduction of computer tomography (CT) in the case ascertainment of intracranial neoplasms has been a raised incidence, in patients over the age of 60, of neoplasms which are not histologically verified.

References

Nov 1, 1976·American Journal of Epidemiology·B S SchoenbergJ P Whisnant
Nov 1, 1988·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·A HelsethS J Mørk
Mar 1, 1971·Journal of Chronic Diseases·U LeibowitzM Alter
May 15, 1967·International Journal of Cancer. Journal International Du Cancer·R Doll, P Cook
Jan 22, 1983·British Medical Journal·J R BradshawM J Campbell
Mar 1, 1984·Acta Neurologica Scandinavica·R FogelholmK Murros
Jan 1, 1982·Annals of the New York Academy of Sciences·L T KurlandC A Molgaard

❮ Previous
Next ❯

Citations

May 30, 1991·International Journal of Cancer. Journal International Du Cancer·T J EideO Søoreide
May 24, 2003·Neurosurgery·Helle Collatz ChristensenChristoffer Johansen
Jul 1, 1993·Journal of Neuro-oncology·M WrenschM Yost
Aug 1, 1993·American Journal of Industrial Medicine·H C Shah
Jul 1, 1989·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·A HelsethS Tretli
Jan 1, 1990·Annals of the New York Academy of Sciences·A Ahlbom
Dec 15, 1994·International Journal of Cancer. Journal International Du Cancer·D ShuggD Roder
Dec 4, 2003·International Journal of Cancer. Journal International Du Cancer·Stefan LönnMaria Feychting
Jun 15, 2010·Journal of Neuro-oncology·Rafael Fuentes-RaspallRafael Marcos-Gragera
Dec 1, 1992·Neuropathology and Applied Neurobiology·L BøH Nyland
Sep 4, 1996·International Journal of Cancer. Journal International Du Cancer·J A BaronH O Adami
Mar 15, 1997·Cancer·A FleuryJ Y Delattre
Jan 1, 1995·Annals of Neurology·K RadhakrishnanL T Kurland

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.